Exosens Shares Drop 2.5% and Plunge into Oversold Territory on the SBF 120
The French specialist in night vision and imaging technology for defense continues its slide in mid-morning trading. The stock is at the bottom of the SBF 120, as the Parisian segment moves in the red. The correction is part of a bearish sequence stretching over several weeks.
Exosens falls by 2.66% to €51.25, down from €52.65 the previous day. The stock is among the largest declines in the SBF 120, while the broad index is down 0.37% in the session. The slump is intensifying over time: the decline reaches 13.94% over a week and 20.48% over a month, erasing part of the annual performance which remains at +21.16%. The technical setup is clearly deteriorating. The price is moving below the 20-day moving average (MM20) at €60.67 (a gap of -15.53%) and the 50-day moving average (MM50) at €62.05 (-17.41%), and remains below the 200-day moving average (MM200) at €54.75 (a gap of -6.39%). The RSI at 28 signals a pronounced oversold condition, consistent with the magnitude of the decline in recent sessions.
A €140M Loan from the EIB Fails to Halt the Correction
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The company announced on Thursday that it had secured a credit facility of 140 million euros from the European Investment Bank, backed by the InvestEU program, to finance its R&D activities and industrial investments in the European defense and civilian markets. The day before, the company had launched PhaseStudio, a software for optical wavefront measurement aimed at metrology. These announcements do not halt the correction that began in late May, after breaking the resistance at €66.65 which had preceded a reversal. The stock is now approaching the €52.65 level, identified as a technical support.
Nous avons constaté une forte croissance et une rentabilité.
Exosens continue de bénéficier d'une forte demande pour ses solutions de vision nocturne et d'imagerie numérique.
Risks mentioned
Tensions géopolitiques croissantes pourraient influencer la demande.
Risques liés à l'expansion des capacités de production.
Opportunities identified
Renforcement de la dynamique commerciale dans le marché de la défense.
Recours à des technologies optroniques avancées en pleine expansion.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
